News Link •
Science, Medicine and Technology • 2018-04-18
Swiss-based biotech company Crispr Therapeutics hope to find a way of curing blood disease beta thalassaemia.
China has approved similar gene therapy trials. A trial into treating cancer patients is under way in the USA.
